About HaystackAnalytics
HaystackAnalytics is a company based in Mumbai (India) founded in 2018 by Kiran Kondabagil, Anirvan Chatterjee, and Gaurav Srivastava. HaystackAnalytics has raised $19.77 million across 10 funding rounds from investors including Sun Pharma, Alkem Laboratories and 1Crowd. The company has 1 employees as of April 05, 2024. HaystackAnalytics operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
- Headquarter Mumbai, India
- Employees 1 as on 05 Apr, 2024
- Founders Kiran Kondabagil, Anirvan Chatterjee, Gaurav Srivastava
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Haystackanalytics Private Limited
- Date of Incorporation 04 Sep, 2018
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$474.96 K (USD)90.66as on Mar 31, 2023
-
Net Profit
-$783.71 K (USD)-100.38as on Mar 31, 2023
-
EBITDA
-$817.82 K (USD)-96.2as on Mar 31, 2023
-
Total Equity Funding
$19.77 M (USD)
in 10 rounds
-
Latest Funding Round
$4.28 M (USD), Seed
Sep 18, 2025
-
Investors
Sun Pharma
& 22 more
-
Employee Count
1
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HaystackAnalytics
HaystackAnalytics has successfully raised a total of $19.77M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $4.28 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HaystackAnalytics
HaystackAnalytics has secured backing from 23 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Sun Pharma, Alkem Laboratories and 1Crowd.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital support is provided to seed and early-stage startups.
|
Locked | Locked | Locked | |
|
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investment firm
|
Locked | Locked | Locked |
Investor details for HaystackAnalytics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HaystackAnalytics
Investment portfolio details for HaystackAnalytics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HaystackAnalytics
Detailed financials for HaystackAnalytics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haystackanalytics Comparisons
Peer comparison for HaystackAnalytics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HaystackAnalytics
HaystackAnalytics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
Detailed competitors of HaystackAnalytics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haystackanalytics
Complete news archive for HaystackAnalytics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HaystackAnalytics
HaystackAnalytics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
HaystackAnalytics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anirvan Chatterjee is the current CEO of HaystackAnalytics. They have also founded this company.
HaystackAnalytics is a funded company, having raised a total of $19.77M across 10 funding rounds to date.
As of Apr 05, 2024, the latest employee count at HaystackAnalytics is 1.
Annual revenue of HaystackAnalytics is $474.96K as on Mar 31, 2023.
HaystackAnalytics was founded in 2018 and is headquartered in Mumbai, India. Operations focus on the genomics sector, where clinical-genomics diagnostic tests are developed and offered. These include the Universal Infectious Diseases Test (UID), a next-generation sequencing-based, culture-free method for detecting bacterial and fungal pathogens, and the Infexn test, a genomic tool for identifying pathogens and antimicrobial resistance from clinical samples. Services support personalized clinical decisions in infectious disease diagnostics.
HaystackAnalytics's top competitors include Visby Medical, Inflammatix and MeMed.
HaystackAnalytics has 23 investors. Key investors include Sun Pharma, Alkem Laboratories, 1Crowd, STRIVE, and Aroha Technologies.
The valuation of HaystackAnalytics is $5.97M as of Aug 2021.